Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.
30 Oct: open ₹323.05, high ₹325.95, low ₹311.10
52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,919 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 57,86658.2% delivered
Panacea Biotec share news and announcements
875 announcements, routine notices left out, newest first. Page 17 of 18.
Aug 2009
19 Aug · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated August 19, 2009, titled "EasyFive* Injects Cheer for Panacea Biotec; USD 222.37 million Award for Panacea Biotec by UNICEF". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Aug · Limited Review Report
Panacea Biotec Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Aug · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Un-Audited Financial Results for the quarter ended June 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on July 30, 2009) regarding the Auditor's observations in their report on the Audited Accounts for the financial year 2008-09. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
30 Jul · Meeting
Panacea Biotec Ltd. has informed the Exchange that the Board of Directors, at their meeting held on July 30, 2009 has decided as under: i) the Annual General Meeting of the Company has been convened to be held on September 25, 2009, and ii) the Register of Members and Share Transfer Books will remain closed from September 23, 2009 to September 25, 2009 (both days inclusive) for the purpose of Annual General Meeting.30 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated July 30, 2009, titled "Panacea Biotec reports financial results for the First Quarter ended 30 June, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jul · Board meeting
To inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2009.
May 2009
27 May · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Audited Financial Results for the year ended March 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on May 27, 2009) regarding the Auditor's observations in their report on the Audited Accounts for the financial year 2008-09. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 May · Updates
Panacea Biotec Ltd. has informed the Exchange that the board of Directors at its meeting held on May 27, 2009, has not recommended any dividend on the Equity Shares of the Company for the financial year ended 31st March, 2009.27 May · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated May 27, 2009, titled "Panacea Biotec reports financial results for the Quarter & Year Ended March 31, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 May · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial Year 2008-2009.
Apr 2009
27 Apr · Results
Panacea Biotec Ltd. has informed the Exchange that the Company will be publishing the Audited Results for the Financial Year ended March 31, 2009 within the stipulated period i.e. upto June 30, 2009 and the Unaudited Financial Results for the last quarter of the Financial Year (quarter ended on March 31, 2009) will not be published.
Feb 2009
13 Feb · Rating
Panacea Biotec Ltd. has informed the Exchange that: "Panacea Biotec Ltd. has been assigned 'CARE A' (Single A) rating to the long term facilities and 'PR1' (PR one) to the short term facilities of the Company by Credit Analysis & Research Ltd. (CARE). 'CARE A' (Single A) rating is applicable to facilities having tenure of more than one year. Facilities of this rating are considered to offer adequate safety for timely servicing of debt obligations. Such facilities carry low credit risk. 'PR1' (PR one) rating is assigned to short term bank facilities having tenure of upto one year. Facilities of this rating would have strong capacity for timely payment of short term debt obligations and carry lowest credit risk. The total bank facilities rated amounted to Rs.1,407.88 Crore".6 Feb · Disclosure
Panacea Biotec Ltd. has informed the Exchange regarding the disclosure of Shareholding under regulation 7(3) of Substantial Acquisition of shares and Takeover Regulations, 1997 and regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulation, 1992 of First Lucre Partnership Co. (including its Persons Acting in Concert). The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Feb · Limited Review Report
Panacea Biotec Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
29 Jan · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on January 29, 2009) regarding the Auditor's observations in their report on the Audited Accounts for the financial year 2007-08. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 29, 2009, titled "Panacea Biotec reports unaudited financial results for the Quarter & Nine Months Ended December 31, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jan · Board meeting
Meeting on 29 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
20 Nov · Disclosure
Panacea Biotec Ltd. has informed the Exchange regarding the disclosure of Shareholding under regulation 7(3) of Substantial Acquisition of Shares and Takeover Regulations, 1997 and regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992, with respect to First Lucre Partnership Co. and Second Lucre Partnership Co. (including its Persons Acting in Concert). The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Nov · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated October 31, 2008, titled "Panacea Biotec reports unaudited financial results for the Quarter & Half Year Ended September 30, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
17 Oct · Board meeting
Company had informed the Exchange that a Meeting of the Board of Directors of the Company will be held on October 17, 2008, to inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter as well as half-year ended September 30, 2008. The Company has now informed the Exchange that due to non-availability of quorum the Board meeting of the Company could not be held on October 17, 2008 and will now be held on October 31, 2008.16 Oct · Meeting
Panacea Biotec Ltd. has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 27, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Oct · Business
Panacea Biotec Ltd. has informed the Exchange regarding the press release dated October 01, 2008, titled "Panacea Biotec enters into Strategic Alliance with PharmAthene, US in Biodefense and Emerging Infectious Diseases. Panacea Biotec to make a US $13.1 Million Strategic Investment in PharmAthene, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
30 Sep · Results
Panacea Biotec Ltd. has informed the Exchange that the result for the resolutions passed by postal ballot has been announced by chairman on September 27, 2008 for voting conducted through Postal Ballot on : 1) for increase in the borrowing powers of the Board of Directors upto Rs. 1500 Crore and 2) authorizing the Board of Directors to mortgage and/ or charge/hypothecate any of its movable and/ or immovable properties or the whole or substantially the whole of an undertaking or undertakings of the Company. Further, the Ordinary resolutions have been approved by the shareholders with the overwhelming majority. A copy of the Result of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Sep · Updates
Panacea Biotec Ltd. has informed the Exchange that with reference to the recent news in newspaper regarding WHO not approving any new vaccine from India because of the Indian Regulatory system failing to meet quality benchmarks, the Company would life to clarify that the development would not affect its ongoing business. Further the Company has submitted a copy of the statement being released to the media, etc. in this regard. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Sep · Board meeting
To inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter as well as half-year ended September 30, 2008.5 Sep · Dividend
Panacea Biotec Ltd. has informed the Exchange that the dividend, if declared at the forthcoming Annual General Meeting, will be paid on or before October 26, 2008.
Aug 2008
20 Aug · Meeting
Panacea Biotec Ltd. has informed the Exchange that as per Section 192A of the Companies Act, 1956 read with Companies (Passing of Resolution by Postal Ballot) Rules, 2001, proposal for creation of mortgage/charge and/or hypothecation from time to time on all the immovable and movable properties present & future of the Company under section 293(1)(a) of the Companies Act, 1956 has to be approved by the shareholders of the Company by way of a postal Ballot. Similarly the approval of shareholders under section 293(1)(d) of the Act for increase in the borrowing powers of the Board of Directors of the Company can be obtained by way of postal Ballot. The Company has appointed Mr. U.K. Singhal of M/s. Singhal Law Associates, Advocates, as Scrutinizer to scrutinize the Postal Ballot in a fair and transparent manner. The duly completed postal ballot form should reach the scrutinizer before the close of working hours, on or before September 13, 2008. The Scrutinizer will submit his report to the chairman and the result of the postal ballot will be announced by the Chairman at the Annual General Meeting scheduled to be held on September 27, 2008. A copy of the notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Aug · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated August 12, 2008, titled "Panacea Biotec bags Award (USD 34.2 million) for Pentavalent Vaccine EasyFive* from UNICEF". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Aug · Limited Review Report
Panacea Biotec Ltd. has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
29 Jul · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended June 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on July 28, 2008) regarding the Auditor's observations in the company's report on the Audited Accounts for the financial year 2007-08. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jul · Meeting
Panacea Biotec Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on July 28, 2008 has decided as under: (1) The Annual General Meeting of the Company has been convened to be held on September 27, 2008. (2) The Register of members and Share Transfer Books will remain closed from September 23, 2008 to September 27, 2008 (both days inclusive) for the purpose of Annual General Meeting and ascertaining the list of members entitled to receive the dividend on Equity Shares, if any, declared at the said meeting.28 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated July 28, 2008, titled "Panacea Biotec reports unaudited financial results for the Quarter ended June 30, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jul · Results
Panacea Biotec Ltd. has informed the Exchange that the result for the resolutions passed by postal ballot has been announced by chairman on July 14, 2008. The result of the voting conducted through Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Jul · Board meeting
Meeting on 28 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”10 Jul · Business
Panacea Biotec Ltd. has informed the Exchange that: "The Company has received WHO prequalification for its fully liquid innovative combination Pentavalent vaccine, EasyFive against five deadly infectious diseases (DTwP+ Hep B+ Hib) of early childhood. This feat comes close on heels of the Company's pre-qualification by WHO for two other combination vaccines, EasyFour (DTP + Hib) and Ecovac (DTP + Hep B) in January this year. In a notification, WHO has advised the UN procuring agencies regarding the acceptability of these vaccines world-wide". Further, the Company has submitted to the Exchange a copy of the press release in this regard, dated July 10, 2008, titled "Panacea Biotec pre-qualified by WHO for supply of Pentavalent Vaccine, EasyFive* to UN agencies". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding the press release dated July 09, 2008, titled "Panacea Biotec receives US Patent for 'Thank God' ".A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jul · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated July 04, 2008, titled "Panacea Biotec forays into Healthcare Delivery - Enters collaboration to set-up 220 bed multi super-specialty hospital in NCR". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
26 Jun · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated June 26, 2008, titled "Panacea Biotec reports audited financial results for the Quarter and Financial Year Ended March 31, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Jun · Dividend
Panacea Biotec Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on June 26, 2008 has recommended dividend @ 100% (i.e. Re. 1/- per Share) on Equity Shares of the Company, for the financial year 2007-08.16 Jun · Meeting
Panacea Biotec Ltd. has informed the Exchange that as per Section 192A of the Companies Act, 1956 read with Companies (Passing of Resolution by Postal Ballot) Rules, 2001, proposal for alteration in Objects Clause of Memorandum of Association has to be approved by the shareholders of the Company by way of a Postal Ballot. Similarly the approval of shareholders under Section 149(2A) of the Act for commencement of any object(s) covered under Other Objects clause of the Memorandum of Association can be obtained by way of Postal Ballot. Accordingly, the shareholders consent for following resolutions is being seek through Postal Ballot: (1) Special Resolution under Section 17 of the Companies Act, 1956 for alteration in Objects Clause by way of inserting new sub-clause 39, 40 & 41 after the existing sub-clause 38 of Clause III-C ( Other Objects ). (2) Special Resolution under Section 149(2A) of the Act for approval for commencement of Objects mentioned under new sub-clauses 39, 40 & 41 of Clause III-C (Other Objects).The duly completed postal ballot form should reach the scrutinizer before the close of working hours, on or before July 02, 2008. The Company has appointed Mr. Sandeep Agarwal of M/s. U.S. & Associates, Company Secretaries, as Scrutinizer to scrutinize the Postal Ballot in a fair and transparent manner. The Scrutinizer will submit his report to the chairman and the result of the postal ballot will be announced by the Chairman on July 14, 2008. A copy of the notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Jun · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial Year 2007-08 and to recommend dividend, if any, on the Share Capital of the Company.
Apr 2008
16 Apr · Results
Panacea Biotec Ltd. has informed the Exchange that : "The Company will be publishing the Audited Results for the Financial Year ended 31st March, 2008 within three months period i.e. upto 30th June, 2008 and the Unaudited Financial Results for the last quarter of the Financial Year (i.e. quarter ended on 31st March, 2008) will not be published."
Mar 2008
18 Mar · Limited Review Report
Panacea Biotec Ltd. has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2007. The details of the limited review report shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
11 Feb · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated February 11, 2008, titled "Panacea Biotec inaugurates GRAND-fifth R&D Centre at Navi Mumbai". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
28 Jan · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31,2007 (taken on record by the Board of Directors of the Company at its meeting held on January 24, 2008) regarding the Auditor's observations in the company's report on the Audited Accounts for the financial year 2006-07. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 24, 2008, titled "Panacea Biotec reports unaudited financial results for the Quarter and nine months ended December 31, 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Jan · Board meeting
Company had informed the Exchange regarding a Board Meeting scheduled to be held on January 23, 2008, to inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter as well as nine months ended December 31, 2007. The Company has now informed the Exchange that inadvertently the date of Board Meeting was mentioned as January 23, 2008 instead of January 24, 2008. The meeting of the Board of Directors will be held on January 24, 2008.9 Jan · Demise of Director
Panacea Biotec Ltd. has informed the Exchange that: "Mr. Manohar Lal Kalra ceased to be the Director of the Company in view of his sad demise on 6th January, 2008".4 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 04, 2008, titled "WHO pre- qualifies Panacea Biotec for supply of EasyFour and Ecovac Vaccines". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Jan · Board meeting
Meeting on 23 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”